Phase 3 confirmatory, randomised 1:1 double-blind, placebo-controlled study evaluating the analgesic efficacy of capsaicin 8% patches in chronic coccygodynia. CAPSACOX Study.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-504644-34-00

Acronym

RC22_0415

Enrollment

188

Registered

2023-08-08

Start date

2023-11-08

Completion date

Unknown

Last updated

2024-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subject with chronic coccygodynia

None listed

Sex/Gender

All

Age

18 Years to No maximum

France

None listed

Source: EU CTIS · Data processed: Feb 4, 2026